Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
OBJECTIVE
To highlight newly revised guidelines on sterile medication compounding released by the United States Pharmacopeia (USP 797) in December 2007, and the implications on immunotherapy vial preparation.


METHODS
A policy review.


RESULTS
The newly revised USP chapter on sterile medication guidelines was released December 2007 and becomes effective June 2008. The revised USP 797 now has specific guidelines addressing immunotherapy vial preparation that are a significant change from the previous version. The revised guidelines should be a useful tool for clinicians who are developing and setting office mixing standards.


CONCLUSIONS
Offices preparing immunotherapy vials should consider formalizing and implementing vial preparation guidelines. These guidelines should be based on expert opinion, experience, and scientific literature.
Lin
Sandra Y
SY
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA. slin30@jhmi.edu
Houser
Steven M
SM
Gross
Gary
G
Aaronson
Donald
D
D004304:Dosage Forms; D004339:Drug Compounding / Q000592:standards*; D017408:Guidelines as Topic; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D007167:Immunotherapy / Q000379:methods; D010602:Pharmacopoeias as Topic; D013242:Sterilization / Q000592:standards*; D014481:United States
D004304:Dosage Forms